- General cross-coupling reactions with adaptive dynamic homogeneous catalysisGhosh, Indrajit; Shlapakov, Nikita; Karl, Tobias A.; Dueker, Jonas; Nikitin, Maksim ; et al, Nature (London, 2023, 619(7968), 87-93
Cas no 94-24-6 (Tetracaine)
Tetracaine Chemical and Physical Properties
Names and Identifiers
-
- 2-(Dimethylamino)ethyl 4-(n-butylamino)benzoate
- tetracaine usp
- tetracaine free base
- Tetracaine Base
- amethocaine
- Dimethylaminoethylnbutylaminobenzoate
- Tetracaine
- 2-(dimethylamino)ethyl 4-(butylamino)benzoate
- TETRACAINE BASE CRYSTALLINE
- Anetain
- Cetacaine
- Contralgin
- Dicaine
- dicaine base
- Pontocain
- Pontocaine
- Tetracaina
- Tetracainum
- Tetrakain
- Uromucaesthin
- 4-(Butylamino)benzoic Acid 2-(Dimethylamino)ethyl Ester
- Tetracacine
- Laudocaine
- Metraspray
- Meethobalm
- Mucaesthin
- Rexocaine
- Medicaine
- Intercain
- Niphanoid
- Fissucain
- Dicain
- Dikain
- Medihaler-Tetracaine
- 2-(Dimethylamino)ethyl p-(butylamino)benzoate
- p-Butylaminobenzoyl-2-dimethylaminoethanol
- Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester
- Tetrakain [Czech]
- Tetracainum [INN-Latin]
- Tetracaina [INN-Sp
- Dlcalne
- Benzoic acid, p-(butylamino)-, 2-(dimethylamino)ethyl ester (8CI)
- 2-Dimethylaminoethyl p-butylaminobenzoate
- Ametop
- Butylocaine
- MeSH ID: D013748
- β-Dimethylaminoethyl p-butylaminobenzoate
- β-Dimethylaminoethyl p-N-butylaminobenzoate
- Diaethylaminoaethanol ester der p-butylaminobenzoesaeure
- Tetracaine (USP:INN:BAN)
- CAS-136-47-0
- SDCCGSBI-0051178.P005
- AB00053549_13
- D00551
- Tetracaine, >=98% (TLC)
- NCGC00016049-04
- BDBM50017659
- KBioSS_001512
- BRD-K45071273-003-05-8
- InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H
- Diathylaminoathanol ester der p-butylaminobenzosaure
- BSPBio_000382
- Q419608
- Prestwick1_000571
- 4-14-00-01172 (Beilstein Handbook Reference)
- TETRACAINE [USP-RS]
- NCGC00162367-01
- FranklyNumb 3
- p-(butylamino)benzoic acid beta-(dimethylamino)ethyl ester
- Tetracaine cream
- Spectrum_001032
- MFCD00053787
- DTXCID9023883
- aniline, N-butyl-4-(2-dimethylaminoethoxycarbonyl)-
- AB00053549_12
- D04AB06
- Pantocaine (Salt/Mix)
- Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]
- TETRACAINE (EP MONOGRAPH)
- CHEBI:9468
- TETRACAINE [EP MONOGRAPH]
- Epitope ID:174843
- Prestwick2_000571
- AKOS015889234
- BCP0726000001
- BPBio1_000422
- 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]
- TETRACAINE [MART.]
- Tetracaine (USP/INN)
- NINDS_000607
- Numfast Tetracaine Green
- TETRACAINE (MART.)
- Tetracaine Powder Tetracaina
- DA-78348
- SYNERA COMPONENT TETRACAINE
- TE4
- KBioGR_000781
- SCHEMBL34714
- SPBio_002601
- C07526
- 2-(Dimethylamino)ethyl 4-(butylamino)benzoate #
- Amethocaine (TN)
- TETRACAINE [INN]
- TETRACAINE [VANDF]
- EINECS 202-316-6
- KBio3_001444
- HY-A0079
- Q-201805
- BRD-K45071273-003-15-7
- Tetracainum (INN-Latin)
- Prestwick0_000571
- Burn Solution Cream
- TETRACAINE (USP MONOGRAPH)
- EN300-6748839
- 100311-22-6
- Lopac0_001211
- 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove
- STL483844
- ALBB-025902
- TETRACAINE [USP MONOGRAPH]
- TETRACAINE COMPONENT OF SYNERA
- CCG-205285
- Tetracaine, meets USP testing specifications
- Spectrum2_001328
- BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
- C05AD02
- Dimethylaminoethyl p-butyl-aminobenzoate
- NS00008930
- AC-3480
- AS-81743
- TETRACAINE [WHO-DD]
- Landocaine
- DTXSID1043883
- BSPBio_001944
- Spectrum3_000562
- BLT 3
- Amethocaine HCl
- p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester
- BRN 2216051
- IDI1_000607
- Prestwick3_000571
- S01HA03
- BCP04777
- .beta.-Dimethylaminoethyl p-butylaminobenzoate
- Tetracaine, United States Pharmacopeia (USP) Reference Standard
- TETRACAINE [GREEN BOOK]
- BRD-K45071273-003-25-6
- BCPP000048
- BRD-K45071273-003-24-9
- Tetracaina [INN-Spanish]
- NCGC00016049-14
- KBio2_006648
- Tetracaina (INN-Spanish)
- KBio2_001512
- Spectrum5_001072
- AB00053549
- CHEMBL698
- NCGC00016049-02
- KBio1_000607
- T2789
- NCGC00016049-01
- SY066710
- SBI-0051178.P004
- KBio2_004080
- Spectrum4_000351
- SPBio_001455
- DivK1c_000607
- 0619F35CGV
- Tetracain
- TETRACAINE [ORANGE BOOK]
- AB00053549-11
- Tetracaine [USP:INN:BAN]
- BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER
- UNII-0619F35CGV
- DB09085
- Lopac-T-7508
- benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester ,hydrochloride
- NCGC00016049-03
- N01BA03
- 94-24-6
- TETRACAINE (USP-RS)
-
- MDL: MFCD00053787
- Inchi: 1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3
- InChI Key: GKCBAIGFKIBETG-UHFFFAOYSA-N
- SMILES: O=C(C1C=CC(NCCCC)=CC=1)OCCN(C)C
Computed Properties
- Exact Mass: 264.18400
- Monoisotopic Mass: 264.184
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 19
- Rotatable Bond Count: 9
- Complexity: 249
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 3
- XLogP3: 3.7
- Topological Polar Surface Area: 41.6
Experimental Properties
- Color/Form: Powder
- Density: 1.0200 (rough estimate)
- Melting Point: 41.0 to 45.0 deg-C
- Boiling Point: 389.4℃ at 760 mmHg
- Flash Point: 189.3±23.7 °C
- Refractive Index: 1.5800 (estimate)
- PSA: 41.57000
- LogP: 2.69000
- Solubility: Not determined
- Vapor Pressure: 0.0±0.9 mmHg at 25°C
Tetracaine Security Information
-
Symbol:
- Prompt:dangerous
- Signal Word:Danger
- Hazard Statement: H301
- Warning Statement: P264-P270-P301+P310+P330-P405-P501
- Hazardous Material transportation number:UN 2811
- Hazard Category Code: R22;R40;R42/43
- Safety Instruction: S22-S36/37
- RTECS:DG4725000
-
Hazardous Material Identification:
- HazardClass:6.1
- PackingGroup:III
- Storage Condition:0-10°C
- Risk Phrases:R22; R40; R42/43
Tetracaine Customs Data
- HS CODE:2922499990
- Customs Data:
China Customs Code:
2922499990Overview:
2922499990 Other amino acids and their esters and their salts(Except those containing more than one oxygen-containing group). VAT:17.0% Tax refund rate:9.0% Regulatory conditions:AB(Customs clearance form for Inbound Goods,Customs clearance form for outbound goods) MFN tariff:6.5% general tariff:30.0%
Declaration elements:
Product Name, component content, use to, The color of ethanolamine and its salt should be reported, The package of ethanolamine and its salt shall be declared
Regulatory conditions:
A.Customs clearance form for Inbound Goods
B.Customs clearance form for outbound goodsInspection and quarantine category:
P.Imported animals and plants\Quarantine of animal and plant products
Q.Outbound animals and plants\Quarantine of animal and plant products
R.Sanitary supervision and inspection of imported food
S.Sanitary supervision and inspection of exported food
M.Import commodity inspection
N.Export commodity inspectionSummary:
HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%
Tetracaine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | T162325-100g |
Tetracaine |
94-24-6 | >98.0%(GC) | 100g |
¥1234.90 | 2023-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | T162325-25g |
Tetracaine |
94-24-6 | >98.0%(GC) | 25g |
¥372.90 | 2023-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | T162325-5g |
Tetracaine |
94-24-6 | >98.0%(GC) | 5g |
¥112.90 | 2023-08-31 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T87620-25g |
Tetracaine |
94-24-6 | 99% | 25g |
¥308.0 | 2023-09-06 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T87620-1g |
Tetracaine |
94-24-6 | 1g |
¥48.0 | 2021-09-07 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 1649991-50MG |
Tetracaine |
94-24-6 | 50mg |
¥3199.48 | 2023-09-06 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | Y0002117 |
Tetracaine |
94-24-6 | European Pharmacopoeia (EP) Reference Standard | ¥2423.32 | 2022-02-21 | ||
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce45918-1g |
Tetracaine (Amethocaine) |
94-24-6 | 98% | 1g |
¥445.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce45918-5g |
Tetracaine (Amethocaine) |
94-24-6 | 98% | 5g |
¥801.00 | 2023-09-08 | |
| TRC | T291338-5g |
Tetracaine |
94-24-6 | 5g |
$ 68.00 | 2023-09-06 |
Tetracaine Production Method
Production Method 1
Production Method 2
- Chemoselective synthesis of tertiary and secondary amines by reductive amination of aldehydesXiong, Wan-Jin; Li, Lei; Li, Jiang-Tao; Zhang, Shi-Qiang; Tang, Jun-Lei; et al, Tetrahedron Letters, 2023, 127,
Production Method 3
- Visible Light-Mediated (Hetero)aryl Amination Using Ni(II) Salts and Photoredox Catalysis in Flow: A Synthesis of TetracainePark, Boyoung Y. ; Pirnot, Michael T.; Buchwald, Stephen L., Journal of Organic Chemistry, 2020, 85(5), 3234-3244
Production Method 4
Production Method 5
- Enabling Reductive C-N Cross-Coupling of Nitroalkanes and Boronic Acids by Steric Design of P(III)/P(V)=O CatalystsLi, Gen ; Kanda, Yuzuru ; Hong, Seung Youn; Radosevich, Alexander T., Journal of the American Chemical Society, 2022, 144(18), 8242-8248
Production Method 6
- Effect of Noxyflex (noxythiolin) on the behavior of animals which have been infected intraperitoneally with suspensions of faecesHaler, David, Internationale Zeitschrift fuer Klinische Pharmakologie, 1974, 9(2), 160-4
Production Method 7
- Cobalt catalyzed chemoselective reduction of nitroarenes: hydrosilylation under thermal and photochemical reaction conditionsPanda, Surajit; Nanda, Amareshwar; Behera, Rakesh R.; Ghosh, Rahul; Bagh, Bidraha, Chemical Communications (Cambridge, 2023, 59(30), 4527-4530
Production Method 8
- Manganese-Catalyzed Chemoselective Hydrosilylation of Nitroarenes: Sustainable Route to Aromatic AminesBehera, Rakesh R.; Panda, Surajit; Ghosh, Rahul; Kumar, A. Ashis; Bagh, Bidraha, Organic Letters, 2022, 24(50), 9179-9183
Production Method 9
- Process for preparation of tetracaine hydrochloride, China, , ,
Production Method 10
- A photochemical dehydrogenative strategy for aniline synthesisU. Dighe, Shashikant ; Julia, Fabio; Luridiana, Alberto ; Douglas, James J.; Leonori, Daniele, Nature (London, 2020, 584(7819), 75-81
Production Method 11
Production Method 12
1.2 Reagents: Sodium carbonate Solvents: Water ; pH 10, rt
- Photocatalytic C-N cross-coupling mediated by heterogeneous nickel-coordinated carbon nitrideZhu, Qi; Zhao, En; Shen, Yajing; Chen, Zupeng; Fang, Weiwei, Organic & Biomolecular Chemistry, 2023, 21(20), 4276-4281
Production Method 13
Production Method 14
Production Method 15
- Process for purification of 4-(butylamino)-benzoic acid 2-(dimethylamino)ethyl ester hydrochloride, China, , ,
Production Method 16
- Co-crystals of calixarenes and biologically active molecules, France, , ,
Production Method 17
- The effect of verapamil, lanthanum and local anesthetics on serotonin release from rabbit plateletsZilberman, Yael; Gutman, Yehuda; Koren, Ruth, Biochimica et Biophysica Acta, 1982, 691(1), 106-14
Tetracaine Raw materials
- (2-chloroethyl)dimethylamine hydrochloride
- 2-(Dimethylamino)ethyl 4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate
- 4-(Butylamino)benzoic acid
- methyl 4-(butylamino)benzoate
- sunbrella
- Ethyl 4-(Butylamino)benzoate(4-(Butylamino)benzoic Acid Ethyl Ester)
- Benzoic acid, 4-amino-,2-(dimethylamino)ethyl ester
- Benzoic acid, 4-bromo-, 2-(dimethylamino)ethyl ester
Tetracaine Preparation Products
Tetracaine Suppliers
Tetracaine Related Literature
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
Additional information on Tetracaine
Tetracaine: A Comprehensive Overview
Tetracaine, also known by its CAS number 94-24-6, is a well-known compound in the field of pharmacology and medicine. It is primarily recognized as a local anesthetic, widely used in various medical applications due to its ability to effectively block nerve impulses and provide temporary relief from pain. This compound has been extensively studied and utilized in clinical settings, making it a significant topic of interest for researchers and practitioners alike.
The chemical structure of Tetracaine plays a crucial role in its pharmacological activity. It belongs to the class of benzocaine derivatives, which are characterized by their ability to inhibit the transmission of nerve signals. Recent studies have highlighted the importance of understanding the molecular mechanisms underlying Tetracaine's action, particularly its interaction with sodium channels. These findings have provided valuable insights into optimizing its use and minimizing potential side effects.
In terms of clinical applications, Tetracaine is commonly employed in ophthalmology, otolaryngology, and dermatology. Its ability to provide rapid onset of anesthesia makes it particularly suitable for procedures requiring precise control over sensory input. For instance, in ophthalmic surgery, Tetracaine eye drops are frequently used to anesthetize the cornea, ensuring patient comfort during examinations and minor surgical interventions.
Recent advancements in research have focused on enhancing the delivery mechanisms of Tetracaine to improve its efficacy and reduce systemic absorption. One promising approach involves the use of nanotechnology-based delivery systems, such as lipid nanoparticles or hydrogels. These innovations aim to prolong the duration of anesthetic effects while minimizing adverse reactions, thereby expanding the scope of Tetracaine's applications.
The safety profile of Tetracaine has also been a subject of extensive investigation. While it is generally well-tolerated when used appropriately, potential risks such as allergic reactions or toxicity must be carefully managed. Emerging studies emphasize the importance of individualized dosing regimens based on patient-specific factors, including age, weight, and medical history.
In conclusion, Tetracaine remains a cornerstone in local anesthesia due to its proven efficacy and versatility across multiple medical disciplines. As research continues to uncover new insights into its mechanisms and applications, Tetracaine is poised to remain a critical component of modern healthcare practices.
94-24-6 (Tetracaine) Related Products
- 19614-15-4(ethyl 4-(morpholin-4-yl)benzoate)
- 84-74-2(Dibutyl phthalate)
- 87-25-2(Ethyl anthranilate)
- 4740-24-3(4-(Butylamino)benzoic acid)
- 545375-30-2(Ethanolamine benzoate hydrochloride)
- 136-47-0(Tetracaine hydrochloride)
- 2208-05-1(Benzoic Acid 2-(Dimethylamino)ethyl Ester)
- 94-32-6(Ethyl 4-(Butylamino)benzoate(4-(Butylamino)benzoic Acid Ethyl Ester))
- 85-68-7(Benzyl butyl phthalate)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)